Revenue - Myomo Inc (F:0M61) - Alpha Spread
Have any thoughts about
Myomo Inc?
Write Note

Myomo Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Myomo Inc
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Myomo Inc
F:0M61
Revenue
$21.1m
CAGR 3-Years
24%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.8B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.2B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$21.4B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.7B
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.6B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
14%

Myomo Inc
Revenue Breakdown

Breakdown by Geography
Myomo Inc

Not Available

Breakdown by Segments
Myomo Inc

Total Revenue: 19.2m USD
100%
Product: 17.5m USD
90.8%
License: 1.8m USD
9.2%

See Also

What is Myomo Inc's Revenue?
Revenue
21.1m USD

Based on the financial report for Jun 30, 2024, Myomo Inc's Revenue amounts to 21.1m USD.

What is Myomo Inc's Revenue growth rate?
Revenue CAGR 5Y
46%

Over the last year, the Revenue growth was 21%. The average annual Revenue growth rates for Myomo Inc have been 24% over the past three years , 46% over the past five years .

Back to Top